FierceBiotech 2026年3月13日 China approves first brain-computer interface implant for paralyzed patients, as sector heats up
FierceBiotech 2026年3月13日 Stop Asking for an AI strategy: 3 questions clinical leaders should ask instead
FierceBiotech 2026年3月12日 Vistagen lays off 20% of staff to tighten focus on struggling social anxiety candidate
FierceBiotech 2026年3月12日 Pfizer Ignite, designed to accelerate promising biotech therapies, fizzles out
FierceBiotech 2026年3月12日 Fledgling French biotech pens $128M deal for Kezar's preclinical protein degrader program
FierceBiotech 2026年3月12日 Ultragenyx gene therapy hits co-primary endpoint in phase 3 rare disease study, teeing up potential win
FierceBiotech 2026年3月12日 Regenxbio posts clean safety profile for DMD gene therapy as pivotal data loom
FierceBiotech 2026年3月12日 Novo Holdings sees assets shrink by a 3rd in wake of Novo Nordisk's nosediving share price
FierceBiotech 2026年3月11日 How a new tool for large-scale gene editing could power novel genetic medicines
FierceBiotech 2026年3月11日 Evotec reveals sweeping 800-person layoffs, more site closures as restructuring rolls on
FierceBiotech 2026年3月11日 CNS Pharma wipes glioblastoma pipeline clean in strategic pivot to fresh neurology, oncology targets
FierceBiotech 2026年3月11日 Despite delays, NIH grants generated a 250% return on $36.6B investment in 2025: report